𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Paroxetine controlled-release formulation in the treatment of major depressive disorder: A randomized, double-blind, placebo-controlled study in Japan and Korea

✍ Scribed by Teruhiko Higuchi; Jin Pyo Hong; Hee-Yeon Jung; Yoshinori Watanabe; Taro Kunitomi; Kunitoshi Kamijima

Book ID
108962707
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
249 KB
Volume
65
Category
Article
ISSN
1323-1316

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hypericum treatment of mild–moderate dep
Hypericum treatment of mild–moderate depression in a placebo–controlled study. A prospective, double–blind, randomized, placebo–controlled, multicentre study
✍ E. Schrader; B. Meier; A. Brattström 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 2 views

A prospective, randomized, multicentre, double-blind placebo controlled study is described which compares the ecacy and tolerability of hypericum administered as a concentrated ethanolic extract of St John's wort (ZE117) to patients with mild±moderate depression (ICD-10; F 32 . 0 mild; F 32 . 1 mode

Is viloxazine an antidepressant? A place
Is viloxazine an antidepressant? A placebo-controlled double-blind study in major depressive disorder presenting in a general hospital
✍ C. Thompson; G. Isaacs 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 596 KB

## Abstract Viloxazine was one of the first of the ‘second‐generation’ antidepressants. Its relative lack of cardiotoxic, anticholinergic, sedative and seizure‐inducing adverse effects suggested its use as an antidepressant in general hospitals where tricyclic antidepressants might be frequently co

Celecoxib as an adjunct in the treatment
Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study
✍ Fabiano G. Nery; Emel S. Monkul; John P. Hatch; Manoela Fonseca; Giovana B. Zunt 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

## Abstract ## Objective To investigate whether the cox‐2 inhibitor celecoxib has antidepressant effects in bipolar disorder (BD) patients during depressive or mixed phases. ## Methods We studied 28 DSM‐IV BD patients who were experiencing a depressive or mixed episode and were on a stable dose